ATNX NASDAQ
Athenex, Inc.
1W: -42.1%
1M: -82.5%
3M: -92.8%
1Y: -97.9%
3Y: -99.9%
5Y: -99.9%
$0.20
Last traded 2023-05-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2022-01-12
Earliest Filing
2022-02-15
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named ATNX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | target | Seller of rights and leasehold interest in the Dunkirk Facility to ImmunityBio, Inc. | 2022-02-15 | View |
| IBRX ImmunityBio, Inc. | target | Seller of rights and obligations for the Dunkirk Facility manufacturing lease and agreements to ImmunityBio, Inc. | 2022-01-12 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR